What is NDC 33342-144?

33342-144 is the product NDC for Ziprasidone Hydrochloride, Ziprasidone hydrochloride 20 mg/1 capsule, listed with the FDA by Macleods Pharmaceuticals Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Macleods Pharmaceuticals Limited, NDC labeler code 33342. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ziprasidone Hydrochloride?

44 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ziprasidone Hydrochloride NDC 33342-144

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-144Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0144Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
33342-144-09	3334201440933342014409	60 CAPSULE in 1 BOTTLE (33342-144-09)Marketed from Feb 18, 2017
33342-144-12	3334201441233342014412	10 BLISTER PACK in 1 CARTON (33342-144-12) / 10 CAPSULE in 1 BLISTER PACKMarketed from Feb 18, 2017
33342-144-51	3334201445133342014451	300 CAPSULE in 1 BOTTLE (33342-144-51)Marketed from Feb 18, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ziprasidone Hydrochloride
Generic name (nonproprietary): ziprasidone hydrochloride
Active ingredients: Ziprasidone hydrochloride — 20 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Macleods Pharmaceuticals LimitedNDC labeler code 33342
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204375
Marketing start: Feb 18, 2017
Listing expires: Dec 31, 2026
Identifiers: Product ID 33342-144_a28d3d06-0479-4c6a-9e92-34b4ef776ac2SPL ID a28d3d06-0479-4c6a-9e92-34b4ef776ac2SPL set ID 3e0d1436-2e2b-4c34-a9bc-4a6b2ac38af0RxCUI 313776, 313777, 313778, 314286UNII 216X081ORUUPC 0333342144515, 0333342146090, 0333342145093, 0333342145512, 0333342147097, 0333342147516, 0333342146519
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342014409 followed by a unit qualifier and the quantity

Package 33342-0144-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 24, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Ziprasidone capsules are indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. When deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone’s greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs [ see Warnings and Precautions ( 5.3 ) ]. Prolongation of the QTc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricula…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 33342-144

What is NDC 33342-144?: 33342-144 is the product NDC for Ziprasidone Hydrochloride, Ziprasidone hydrochloride 20 mg/1 capsule, listed with the FDA by Macleods Pharmaceuticals Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ziprasidone Hydrochloride.
What is the active ingredient?: Ziprasidone hydrochloride.
Who is the labeler?: Macleods Pharmaceuticals Limited, NDC labeler code 33342. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ziprasidone Hydrochloride?: 44 other product NDCs are listed under this name. See all Ziprasidone Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ziprasidone Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
ziprasidone hydrochlorideziprasidone hcl	Ziprasidone hydrochloride 80 mg/1	CapsuleOral	AvPAK	50268-814	50268-0814-12
ziprasidone hydrochlorideziprasidone hcl	Ziprasidone hydrochloride 20 mg/1	CapsuleOral	AvPAK	50268-811	50268-0811-12
ziprasidone hydrochlorideziprasidone hcl	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	AvPAK	50268-812	50268-0812-12
ziprasidone hydrochlorideziprasidone hcl	Ziprasidone hydrochloride 60 mg/1	CapsuleOral	AvPAK	50268-813	50268-0813-12
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	BluePoint Laboratories	68001-451	68001-0451-06
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 60 mg/1	CapsuleOral	BluePoint Laboratories	68001-452	68001-0452-06
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 80 mg/1	CapsuleOral	BluePoint Laboratories	68001-453	68001-0453-06
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 20 mg/1	CapsuleOral	BluePoint Laboratories	68001-450	68001-0450-06
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-0787	70518-0787-0070518-0787-01
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 60 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-0782	70518-0782-0170518-0782-03

All 45 Ziprasidone Hydrochloride NDCs

Other NDCs under ANDA 204375

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204375
Product	Strength	Form · route	Labeler	Product NDC
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-145
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 60 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-146
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 80 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-147
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	A-S Medication Solutions	50090-5420
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	Bryant Ranch Prepack	63629-3331
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 20 mg/1	CapsuleOral	Bryant Ranch Prepack	63629-8150
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 20 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-0743
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 60 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-0782
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-0787
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 80 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-0501
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 60 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-0585